A large, multicentre, observational, post-marketing surveillance study of the 2:1 formulation of follitropin alfa and lutropin alfa in routine clinical practice for assisted reproductive technology
Open Access
- 1 January 2014
- journal article
- research article
- Published by Springer Nature in Reproductive Biology and Endocrinology
- Vol. 12 (1) , 6
Abstract
Follicle-stimulating hormone (FSH) and luteinizing hormone (LH) both have a role to play in follicular development during the natural menstrual cycle. LH supplementation during controlled ovarian stimulation (COS) for assisted reproductive technology (ART) is used for patients with hypogonadotropic hypogonadism. However, the use of exogenous LH in COS in normogonadotropic women undergoing ART is the subject of debate. The aim of this study was to investigate characteristics of infertile women who received the 2:1 formulation of follitropin alfa and lutropin alfa (indicated for stimulation of follicular development in women with severe LH and FSH deficiency) in German clinical practice.Keywords
This publication has 20 references indexed in Scilit:
- Does exogenous LH in ovarian stimulation improve assisted reproduction success? An appraisal of the literatureReproductive BioMedicine Online, 2012
- Recombinant human LH supplementation versus supplementation with urinary hCG-based LH activity during controlled ovarian stimulation in the long GnRH-agonist protocol: a matched case–control studyGynecological Endocrinology, 2011
- Impact of luteinizing hormone administration on gonadotropin-releasing hormone antagonist cycles: an age-adjusted analysisFertility and Sterility, 2011
- A 2:1 formulation of follitropin alfa and lutropin alfa in routine clinical practice: a large, multicentre, observational studyGynecological Endocrinology, 2010
- Recombinant Luteinizing Hormone (rLH) for controlled ovarian hyperstimulation in assisted reproductive cycles2007
- Understanding the role of LH: myths and factsReproductive BioMedicine Online, 2007
- Exogenous luteinizing hormone in controlled ovarian hyperstimulation for assisted reproduction techniquesFertility and Sterility, 2004
- Effects of recombinant LH supplementation in women undergoing assisted reproduction with GnRH agonist down-regulation and stimulation with recombinant FSH: an opening studyReproductive BioMedicine Online, 2004
- Current concepts and novel applications of LH activity in ovarian stimulationTrends in Endocrinology & Metabolism, 2003
- Recombinant Human Luteinizing Hormone (LH) to Support Recombinant Human Follicle-Stimulating Hormone (FSH)-Induced Follicular Development in LH- and FSH-Deficient Anovulatory Women: A Dose-Finding Study1The Journal of Clinical Endocrinology & Metabolism, 1998